239 related articles for article (PubMed ID: 30987694)
21. Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans.
Liu S; Yue L; Gu W; Li X; Zhang L; Sun S
PLoS One; 2016; 11(3):e0150859. PubMed ID: 26986478
[TBL] [Abstract][Full Text] [Related]
22. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H
BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565
[TBL] [Abstract][Full Text] [Related]
23. The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans.
Sasse C; Schillig R; Dierolf F; Weyler M; Schneider S; Mogavero S; Rogers PD; Morschhäuser J
PLoS One; 2011; 6(9):e25623. PubMed ID: 21980509
[TBL] [Abstract][Full Text] [Related]
24. In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans.
Mahmoud DE; Faraag AHI; Abu El-Wafa WM
World J Microbiol Biotechnol; 2021 Oct; 37(11):191. PubMed ID: 34632522
[TBL] [Abstract][Full Text] [Related]
25. Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of
Černáková L; Dižová S; Gášková D; Jančíková I; Bujdáková H
Microb Drug Resist; 2019; 25(6):805-812. PubMed ID: 30785845
[No Abstract] [Full Text] [Related]
26. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
27. Contribution of Clinically Derived Mutations in the Gene Encoding the Zinc Cluster Transcription Factor Mrr2 to Fluconazole Antifungal Resistance and
Nishimoto AT; Zhang Q; Hazlett B; Morschhäuser J; Rogers PD
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30833425
[TBL] [Abstract][Full Text] [Related]
28. [Effect of Huanglian Jiedu decoction in combination with fluconazole on ergosterol of fluconazole-resistant Candida albicans].
Yan YY; Wang TM; Shi GX; Zhang MX; Lu KQ; Shao J; Wang CZ
Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):727-32. PubMed ID: 26137698
[TBL] [Abstract][Full Text] [Related]
29. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
Reis de Sá LF; Toledo FT; Gonçalves AC; Sousa BA; Dos Santos AA; Brasil PF; Duarte da Silva VA; Tessis AC; Ramos JA; Carvalho MA; Lamping E; Ferreira-Pereira A
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447
[TBL] [Abstract][Full Text] [Related]
30. [Characterization of azole resistance mechanisms in Chilean clinical isolates of Candida albicans].
Fuentes M; Hermosilla G; Alburquenque C; Falconer MA; Amaro J; Tapia C
Rev Chilena Infectol; 2014 Oct; 31(5):511-7. PubMed ID: 25491448
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
32. Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.
Popp C; Hampe IAI; Hertlein T; Ohlsen K; Rogers PD; Morschhäuser J
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461316
[TBL] [Abstract][Full Text] [Related]
33. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole.
Huang S; Cao YY; Dai BD; Sun XR; Zhu ZY; Cao YB; Wang Y; Gao PH; Jiang YY
Biol Pharm Bull; 2008 Dec; 31(12):2234-6. PubMed ID: 19043205
[TBL] [Abstract][Full Text] [Related]
34. Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0006722. PubMed ID: 35343781
[TBL] [Abstract][Full Text] [Related]
35. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
Khajeh E; Hosseini Shokouh SJ; Rajabibazl M; Roudbary M; Rafiei S; Aslani P; Farahnejad Z
Br J Biomed Sci; 2016; 73(1):44-8. PubMed ID: 27182677
[TBL] [Abstract][Full Text] [Related]
36. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates.
Shi G; Shao J; Wang T; Wu D; Wang C
Biomed Pharmacother; 2017 Sep; 93():709-712. PubMed ID: 28700974
[TBL] [Abstract][Full Text] [Related]
38. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.
Yu LH; Wei X; Ma M; Chen XJ; Xu SB
Antimicrob Agents Chemother; 2012 Feb; 56(2):770-5. PubMed ID: 22106223
[TBL] [Abstract][Full Text] [Related]
39. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
[TBL] [Abstract][Full Text] [Related]
40. The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans.
Shao J; Zhang M; Wang T; Li Y; Wang C
Pharm Biol; 2016; 54(6):984-92. PubMed ID: 26459663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
